These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3605088)

  • 1. Diabetes, dialysate losses, and serum lipids during continuous ambulatory peritoneal dialysis.
    Rubin J; Walsh D; Bower JD
    Am J Kidney Dis; 1987 Aug; 10(2):104-8. PubMed ID: 3605088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipids and lipoproteins during continuous ambulatory peritoneal dialysis.
    Lindholm B; Norbeck HE
    Acta Med Scand; 1986; 220(2):143-51. PubMed ID: 3776689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-month prospective cross-over study to determine the effects of 1.1% amino acid dialysate on lipid metabolism in patients on continuous ambulatory peritoneal dialysis.
    Misra M; Reaveley DA; Ashworth J; Muller B; Seed M; Brown EA
    Perit Dial Int; 1997; 17(3):279-86. PubMed ID: 9237290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal lipid profiles on CAPD: their relationship to weight gain, comorbidity, and dialysis factors.
    Little J; Phillips L; Russell L; Griffiths A; Russell GI; Davies SJ
    J Am Soc Nephrol; 1998 Oct; 9(10):1931-9. PubMed ID: 9773795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential changes in serum lipids and their subfractions in patients receiving continuous ambulatory peritoneal dialysis.
    Ramos JM; Heaton A; McGurk JG; Ward MK; Kerr DN
    Nephron; 1983; 35(1):20-3. PubMed ID: 6888622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of apolipoprotein E genotype on lipid and lipoprotein levels in continuous ambulatory peritoneal dialysis patients.
    Choi KH; Song HY; Shin SK; Noh H; Kang SW; Kim JH; Lee HY; Han DS
    Adv Perit Dial; 1999; 15():243-6. PubMed ID: 10682111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoproteins in children treated with continuous peritoneal dialysis.
    Querfeld U; LeBoeuf RC; Salusky IB; Nelson P; Laidlaw S; Fine RN
    Pediatr Res; 1991 Feb; 29(2):155-9. PubMed ID: 2014151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity in peritoneal transport during continuous ambulatory peritoneal dialysis and its impact on ultrafiltration, loss of macromolecules and plasma level of proteins, lipids and lipoproteins.
    Kagan A; Bar-Khayim Y; Schafer Z; Fainaru M
    Nephron; 1993; 63(1):32-42. PubMed ID: 8446249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term CAPD on carbohydrate and lipid metabolism.
    Lameire N; Matthys D; Matthys E; Beheydt R
    Clin Nephrol; 1988; 30 Suppl 1():S53-8. PubMed ID: 3052961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual renal function affects lipid profile in patients undergoing continuous ambulatory peritoneal dialysis.
    Kagan A; Elimalech E; Lemer Z; Fink A; Bar-Khayim Y
    Perit Dial Int; 1997; 17(3):243-9. PubMed ID: 9237284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body composition and lipid abnormalities in hispanic and black patients on continuous ambulatory peritoneal dialysis.
    Henriquez MA; Gonzalez A; Bemis JA; Esquivel J
    Perit Dial Int; 1993; 13 Suppl 2():S424-7. PubMed ID: 8399630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipids, lipoproteins and apolipoproteins A-I and B and apolipoprotein losses in continuous ambulatory peritoneal dialysis.
    Steele J; Billington T; Janus E; Moran J
    Atherosclerosis; 1989 Sep; 79(1):47-50. PubMed ID: 2803346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biochemical changes with continuous ambulant peritoneal dialysis (CAPD)].
    Fuchs C; Armstrong VW; Dorn D; Ebert R; Scheler F
    Z Urol Nephrol; 1982 Jun; 75(6):415-27. PubMed ID: 6750973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolic parameters of CAPD and CCPD in diabetics with terminal renal insufficiency].
    Thomae U; Kuhlmann H; Herrmann M; Büchele W
    Dtsch Med Wochenschr; 1984 Jun; 109(24):941-4. PubMed ID: 6734446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients.
    Nevalainen P; Lahtela JT; Mustonen J; Pasternack A
    Nephrol Dial Transplant; 1997 Jan; 12(1):145-50. PubMed ID: 9027790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of continuous ambulatory peritoneal dialysis.
    Rubin J; Kirchner K; Barnes T; Teal N; Ray R; Bower JD
    Am J Kidney Dis; 1983 Nov; 3(3):199-204. PubMed ID: 6638015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose concentration in the dialysate does not contribute to lipid profiles in patients undergoing CAPD.
    Li Z; Fengxian H
    Ren Fail; 2011; 33(2):124-30. PubMed ID: 21332332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis.
    Kabanda A; Goffin E; Bernard A; Lauwerys R; van Ypersele de Strihou C
    Kidney Int; 1995 Dec; 48(6):1946-52. PubMed ID: 8587256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
    Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
    Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.